guaiacol has been researched along with Fatty Liver, Nonalcoholic in 4 studies
Guaiacol: An agent thought to have disinfectant properties and used as an expectorant. (From Martindale, The Extra Pharmacopoeia, 30th ed, p747)
methylcatechol : Any member of the class of catechols carrying one or more methyl substituents.
guaiacol : A monomethoxybenzene that consists of phenol with a methoxy substituent at the ortho position.
Excerpt | Relevance | Reference |
---|---|---|
"This study was conducted to test the protective potential of Zingerone against a high-fat diet (HFD)-mediated non-alcoholic fatty liver disease (NAFLD) development in rats and examined in this protection is mediated modulating AMP-activated protein kinase (AMPK)." | 8.12 | Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK. ( Mohammed, HM, 2022) |
"NAFLD is currently one of the most common etiologies of chronic liver disease worldwide." | 5.43 | Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet. ( Jesudoss, VA; Muniandy Narayanan, J, 2016) |
"This study was conducted to test the protective potential of Zingerone against a high-fat diet (HFD)-mediated non-alcoholic fatty liver disease (NAFLD) development in rats and examined in this protection is mediated modulating AMP-activated protein kinase (AMPK)." | 4.12 | Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK. ( Mohammed, HM, 2022) |
"NAFLD is currently one of the most common etiologies of chronic liver disease worldwide." | 1.43 | Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet. ( Jesudoss, VA; Muniandy Narayanan, J, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Mohammed, HM | 1 |
Sim, WC | 1 |
Park, S | 1 |
Lee, KY | 1 |
Je, YT | 1 |
Yin, HQ | 1 |
Choi, YJ | 1 |
Sung, SH | 1 |
Park, SJ | 1 |
Park, HJ | 1 |
Shin, KJ | 1 |
Lee, BH | 1 |
Muniandy Narayanan, J | 1 |
Jesudoss, VA | 1 |
Lee, MS | 1 |
Kim, KJ | 1 |
Kim, D | 1 |
Lee, KE | 1 |
Hwang, JK | 1 |
4 other studies available for guaiacol and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Guaiacol; NF-E2-Related Factor 2; NF-kappa B; Non-alcoholic | 2022 |
LXR-α antagonist meso-dihydroguaiaretic acid attenuates high-fat diet-induced nonalcoholic fatty liver.
Topics: Animals; Base Sequence; Cell Line, Tumor; Diet, High-Fat; DNA Primers; Fatty Liver; Guaiacol; Humans | 2014 |
Hepatoprotective potential of zingerone against nonalcoholic fatty liver disease in rats fed with fructose-enriched diet.
Topics: Animals; Antioxidants; Dietary Sucrose; Fructose; Guaiacol; Lipid Metabolism; Liver; Male; Non-alcoh | 2016 |
meso-Dihydroguaiaretic acid inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in human HepG2 cells.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Cell Culture Techniques; Dose-Response Relati | 2011 |